Imugene is a clinical stage immuno-oncology company developing a range of new treatments that seek to activate the immune system of cancer patients to identify and eradicate tumors.

In the 10/29/2022 live episode of Trending Today, airing on Fox Business, Imugene shared its groundbreaking solutions for cancer treatment. Watch to learn more on how Imugene is developing a range of new treatments that seek to activate the immune system of cancer patients to identify and eradicate tumors. Filming occurred at the prestigious City of Hope Hospital in Pasadena, CA and Imugene’s office in Sydney, Australia.

By developing cancer immunotherapies and transformative cancer medicines, Imugene seeks to bring effective new treatments and options to patients who need them. The Company’s culture revolves around core values including compassion, integrity, innovation, and sustainability, which allows it to establish value and trust with patients, stakeholders, and the medical community. By striving to be bold and brave in their thinking, Imugene continues to progress its cancer medicines with the goal of improving patients’ lives. Imugene’s CEO & Managing Director, Leslie Chong says, “We want to create transformative medicine for cancer patients, not only to give them a second chance at therapeutics, but we want to lead to a cure.”